Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of topical 5-FU cream in patients with clinically relevant DPYD variants
NL-OMON54797Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fluorouracil in actinic keratosis (AK), Bowen disease (BD) and basal cell carcinoma (BCC) (2 arms), sponsored by Erasmus MC. Started Oct 2019; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
actinic keratosis (AK)Bowen disease (BD)basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NL-OMON54797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54797.